Navigation Links
Slowing the allergic march
Date:8/14/2011

PHILADELPHIA - A pandemic of ailments called the "allergic march" -- the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood -- has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.

What causes the march and how to derail it has remained elusive. Now, in this week's Nature, David Artis, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, and a team of collaborating international scientists, identified that expression of the protein TSLP may influence susceptibility to multiple allergic diseases by regulating the maturation of basophils, an uncommon type of white blood cell. Specifically, TSLP elicits the maturation of a population of distinct basophils that promotes allergic inflammation.

"A fundamental question regarding the allergic march is if a child has eczema, for example, which is associated with TSLP production in skin cells, why would some of those children subsequently be more susceptible to other allergic diseases at different sites of the body such as the gut or the lung?" asks Artis. "Although we have known that TSLP is associated with allergic diseases for many years, how this biological messenger might influence multiple allergic diseases has been a puzzle."

The origins of the present study lie in previous reports that showed that different versions of the gene encoding TSLP, an inflammation-producing cytokine, are associated with increased susceptibility to multiple allergic disorders, and that exaggerated TSLP production is associated with asthma, eczema, and food allergies in children. Together, these studies indicate that TSLP could be a critical regulator of multiple cytokine-associated allergic inflammatory diseases.

In this new report, mice overexpressing TSLP developed allergic inflammation in their lungs, skin, and gut that was associated with very high levels of basophils. "The critical findings are that TSLP appears to activate the development and maturation of early-stage basophils in the bone marrow and that TSLP elicits a distinct type of basophil," explains first author Mark Siracusa, PhD, a Ruth L. Kirschstein National Research Service Fellow in the Artis lab. Based on these findings, the researchers speculate that this basophil maturation could promote allergic reactions at multiple tissue sites.

To translate these findings to patient populations, Artis and colleagues teamed up with a group of pediatricians at the Children's Hospital of Philadelphia to examine basophil responses in children that suffer from the food allergy-associated disease, eosinophilic esophagitis, which causes inflammation of the esophagus. Previous studies have shown that TSLP is overexpressed in food allergy patients. The team showed in the Nature paper that in children with food allergies basophils exhibited a different molecular make-up compared to non-allergy patients.

"It's promising that after more than 130 years since basophils were first discovered by Paul Ehrlich in Germany, we are still finding out new things about this cell population that could help in the design of new drugs to prevent or better fight allergic diseases," concludes Artis.

With more than 50 percent of Americans estimated to suffer from at least one allergic disease, says Artis, the team is hoping that targeting TSLP and basophils may offer new therapies for multiple allergic diseases.


'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. Slowing the spread of drug-resistant diseases is goal of new research area
2. Smoking, Obesity Slowing U.S. Life Expectancy Gains: Report
3. Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections
4. Study: Hypoallergenic dogs not less allergic than other dogs
5. Kids Eczema, Hay Fever Linked to Allergic Asthma Later
6. Childhood eczema and hay fever leads to adult allergic asthma
7. Protein associated with allergic response causes airway changes in asthma patients
8. Vaccinated children not at higher risk of infections or allergic diseases
9. Vitamin D may treat and prevent allergic reaction to mold in cystic fibrosis patients
10. Those with allergic asthma face double trouble during flu season, UT Southwestern findings suggest
11. Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Slowing the allergic march
(Date:7/27/2017)... ... July 27, 2017 , ... Georgia Urology , ... Dr. Brent Sharpe who is now serving urology patients in the Braselton and ... in Flowery Branch, and is open on Mondays, Tuesdays, Wednesdays, and Fridays. The Gainesville ...
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... a new set of teeth in a single office visit from Dr. Alejandro ... comfortable treatment solutions to his East Texas patients, including Teeth-in-a-Day® dental implants ...
(Date:7/27/2017)... Santa Clara, CA (PRWEB) , ... July 27, ... ... technology, announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution ... to support accelerated diagnostics and sleep care management. The speed and functionality of ...
(Date:7/27/2017)... ... ... Los Angeles leg of the US movie premier of the Man in the Camo Jacket ... Clive Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA ... rock musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... 11, 2017  Sysmex America, Inc., a leading ... equipment as well as middleware information systems technology, ... make quality assurance easier and more risk free ... known for the innovation that it delivers to ... quality assurance processes to a new level with ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: